Cardiovascular Risk Assessment Using Artificial Intelligence-Enabled Event Adjudication and Hematologic Predictors.

Authors:
Truslow JG; Goto S; Homilius M; Mow C; Higgins JM and 2 more

Journal:
Circ Cardiovasc Qual Outcomes

Publication Year: 2022

DOI:
10.1161/CIRCOUTCOMES.121.008007

PMCID:
PMC9208816

PMID:
35477255

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Circ Cardiovasc Qual Outcomes

Abbreviation: Circ Cardiovasc Qual Outcomes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Dat…
MacDougall DE; Baum SJ; Ahmed CD and 2 more (2024) - Transparency Score: 3/6
Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study.
Reynolds MR; Stein AB; Sun X and 3 more (2023) - Transparency Score: 4/6
Discrimination Experiences and All-Cause and Cardiovascular Mortality: Multi-Ethnic Study of Athero…
Lawrence WR; Jones GS; Johnson JA and 5 more (2023) - Transparency Score: 3/6
Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Cr…
Lu Y; Liu Y; Jastreboff AM and 5 more (2023) - Transparency Score: 3/6
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analys…
Chivardi C; Morgan H; Sculpher MJ and 10 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Dr MacRae is a co-founder of Atman Health RCD: co-founder of Atman Health. The other authors report no conflicts."

Evidence found in paper:

"Sources of Funding This work was supported by One Brave Idea."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025